Young G - Search Results

1

Thalidomide and immunomodulatory derivatives augment natural killer cell cytotoxicity in multiple myeloma.

Davies FE, Raje N, Hideshima T, Lentzsch S, Young G, Tai YT, Lin B, Podar K, Gupta D, Chauhan D, Treon SP, Richardson PG, Schlossman RL, Morgan GJ, Muller GW, Stirling DI, Anderson KC. Davies FE, et al. Among authors: young g. Blood. 2001 Jul 1;98(1):210-6. doi: 10.1182/blood.v98.1.210. Blood. 2001. PMID: 11418482 Free article.

2

CD40 activation induces p53-dependent vascular endothelial growth factor secretion in human multiple myeloma cells.

Tai YT, Podar K, Gupta D, Lin B, Young G, Akiyama M, Anderson KC. Tai YT, et al. Among authors: young g. Blood. 2002 Feb 15;99(4):1419-27. doi: 10.1182/blood.v99.4.1419. Blood. 2002. PMID: 11830495 Free article.

3

Translocation of Ku86/Ku70 to the multiple myeloma cell membrane: functional implications.

Tai YT, Podar K, Kraeft SK, Wang F, Young G, Lin B, Gupta D, Chen LB, Anderson KC. Tai YT, et al. Among authors: young g. Exp Hematol. 2002 Mar;30(3):212-20. doi: 10.1016/s0301-472x(01)00786-x. Exp Hematol. 2002. PMID: 11882358 Free article.

4

Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma.

Raje N, Hideshima T, Davies FE, Chauhan D, Treon SP, Young G, Tai YT, Avigan D, Gong J, Schlossman RL, Richardson P, Kufe DW, Anderson KC. Raje N, et al. Among authors: young g. Br J Haematol. 2004 May;125(3):343-52. doi: 10.1111/j.1365-2141.2004.04929.x. Br J Haematol. 2004. PMID: 15086415 Free article.

5

Elevated soluble MUC1 levels and decreased anti-MUC1 antibody levels in patients with multiple myeloma.

Treon SP, Maimonis P, Bua D, Young G, Raje N, Mollick J, Chauhan D, Tai YT, Hideshima T, Shima Y, Hilgers J, von Mensdorff-Pouilly S, Belch AR, Pilarski LM, Anderson KC. Treon SP, et al. Among authors: young g. Blood. 2000 Nov 1;96(9):3147-53. Blood. 2000. PMID: 11049996 Free article.

6

Tumor Cell Expression of CD59 Is Associated With Resistance to CD20 Serotherapy in Patients With B-Cell Malignancies.

Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC. Treon SP, et al. Among authors: young g. J Immunother (1991). 2001 May;24(3):263-271. J Immunother (1991). 2001. PMID: 11395643

7

Tumor cell expression of CD59 is associated with resistance to CD20 serotherapy in patients with B-cell malignancies.

Treon SP, Mitsiades C, Mitsiades N, Young G, Doss D, Schlossman R, Anderson KC. Treon SP, et al. Among authors: young g. J Immunother. 2001 May-Jun;24(3):263-71. J Immunother. 2001. PMID: 11394505

8

Multiple micronutrient deficiencies in a child fed an elemental formula.

Jones M, Campbell KA, Duggan C, Young G, Bousvaros A, Higgins L, Mullen E. Jones M, et al. Among authors: young g. J Pediatr Gastroenterol Nutr. 2001 Nov;33(5):602-5. doi: 10.1097/00005176-200111000-00016. J Pediatr Gastroenterol Nutr. 2001. PMID: 11740236 No abstract available.

9

Matrix collagen type and pore size influence behaviour of seeded canine chondrocytes.

Nehrer S, Breinan HA, Ramappa A, Young G, Shortkroff S, Louie LK, Sledge CB, Yannas IV, Spector M. Nehrer S, et al. Among authors: young g. Biomaterials. 1997 Jun;18(11):769-76. doi: 10.1016/s0142-9612(97)00001-x. Biomaterials. 1997. PMID: 9177854

10

Transferring managed care principles to VA.

Flynn K, McGlynn G, Young G. Flynn K, et al. Among authors: young g. Hosp Health Serv Adm. 1997 Fall;42(3):323-38. Hosp Health Serv Adm. 1997. PMID: 10169291

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,139 results

Search Page